Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10530-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10530-1-AP, RRID:AB_2161779
- Product name
- PDLIM5 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PDLIM5 antibody (Cat. #10530-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Glial growth factor 2 treatment alleviates ischemia and reperfusion-damaged integrity of the blood-brain barrier through decreasing Mfsd2a/caveolin-1-mediated transcellular and Pdlim5/YAP/TAZ-mediated paracellular permeability.
Ultrasound-mediated mesoporous silica nanoparticles loaded with PDLIM5 siRNA inhibit gefitinib resistance in NSCLC cells by attenuating EMT.
An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus.
Down-regulation of the Smad signaling by circZBTB46 via the Smad2-PDLIM5 axis to inhibit type I collagen expression.
Actin cable formation and epidermis-dermis positional relationship during complete skin regeneration.
Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC.
Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer.
MicroRNA-17-92 regulates myoblast proliferation and differentiation by targeting the ENH1/Id1 signaling axis.
si-RNA-mediated knockdown of PDLIM5 suppresses gastric cancer cell proliferation in vitro.
Zhang XL, Du WH, Qian SX, Lu XD, Yu X, Fang HL, Dong JL, Song M, Sun YY, Wu XQ, Shen YF, Hao YN, Shen MH, Zhou BQ, Wang YP, Xu CY, Jin XC
Acta pharmacologica Sinica 2024 Nov;45(11):2241-2252
Acta pharmacologica Sinica 2024 Nov;45(11):2241-2252
Ultrasound-mediated mesoporous silica nanoparticles loaded with PDLIM5 siRNA inhibit gefitinib resistance in NSCLC cells by attenuating EMT.
Wu H, Lv WH, Zhu YY, Jia YY, Nie F
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2023 Mar 1;182:106372
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2023 Mar 1;182:106372
An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus.
Navickas A, Asgharian H, Winkler J, Fish L, Garcia K, Markett D, Dodel M, Culbertson B, Miglani S, Joshi T, Yin K, Nguyen P, Zhang S, Stevers N, Hwang HW, Mardakheh F, Goga A, Goodarzi H
Nature cell biology 2023 Jun;25(6):892-903
Nature cell biology 2023 Jun;25(6):892-903
Down-regulation of the Smad signaling by circZBTB46 via the Smad2-PDLIM5 axis to inhibit type I collagen expression.
Yu J, Yan WZ, Zhang XH, Zheng B, Pan WS, Yang Z, Zhang H, Nie ZY, Ma Y, Bai Y, Zhang L, Feng DD, Wen JK
Journal of geriatric cardiology : JGC 2023 Jun 28;20(6):431-447
Journal of geriatric cardiology : JGC 2023 Jun 28;20(6):431-447
Actin cable formation and epidermis-dermis positional relationship during complete skin regeneration.
Takaya K, Okabe K, Ishigami A, Imbe Y, Kanazawa H, Sakai S, Aramaki-Hattori N, Kishi K
Scientific reports 2022 Sep 23;12(1):15913
Scientific reports 2022 Sep 23;12(1):15913
Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC.
Su C, Ren X, Yang F, Li B, Wu H, Li H, Nie F
Drug delivery 2022 Dec;29(1):99-110
Drug delivery 2022 Dec;29(1):99-110
Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.
Tian C, Hu G, Gao L, Hackfort BT, Zucker IH
Journal of molecular and cellular cardiology 2020 Jun;143:120-131
Journal of molecular and cellular cardiology 2020 Jun;143:120-131
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer.
Liu X, Chen L, Huang H, Lv JM, Chen M, Qu FJ, Pan XW, Li L, Yin L, Cui XG, Gao Y, Xu DF
Oncotarget 2017 Nov 17;8(58):98117-98134
Oncotarget 2017 Nov 17;8(58):98117-98134
MicroRNA-17-92 regulates myoblast proliferation and differentiation by targeting the ENH1/Id1 signaling axis.
Qiu H, Liu N, Luo L, Zhong J, Tang Z, Kang K, Qu J, Peng W, Liu L, Li L, Gou D
Cell death and differentiation 2016 Oct;23(10):1658-69
Cell death and differentiation 2016 Oct;23(10):1658-69
si-RNA-mediated knockdown of PDLIM5 suppresses gastric cancer cell proliferation in vitro.
Li Y, Gao Y, Xu Y, Sun X, Song X, Ma H, Yang M
Chemical biology & drug design 2015 Apr;85(4):447-53
Chemical biology & drug design 2015 Apr;85(4):447-53
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 10530-1-AP(PDLIM5 antibody) at dilution of 1:250
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PDLIM5 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PDLIM5. This antibody recognizes human,mouse,rat antigen. The PDLIM5 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
